IL10 inhibited LPS-induced TNF-α secretion with results of the two-way ANOVA indicating that the anti-inflammatory action of IL10 was lower in T2D vs. non-T2D control participants (main effect of group, P ≤ 0.05, Fig. 1). This evidence concerns the gene IL10 and type 2 diabetes mellitus.